Showing results (1131-1140 of 1,468) with videos related to

Sort By:
Pageof 147
Journal of Photochemistry and Photobiology. B, Biology|March 22, 2019
Self-assembly of chlorin-e6 on γ-Fe2O3 nanoparticles: Application for larvicidal activity against Aedes aegyptiMassimiliano Magro, Simone Bramuzzo, Davide Baratella, et al.
Iscience|January 1, 2024
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GPEleonora Vianello, Josefine Persson, Björn Andersson, et al.
European Journal of Medicinal Chemistry|March 14, 2015
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blastsSergio Valente, Veronica Rodriguez, Ciro Mercurio, et al.
European Journal of Human Genetics : EJHG|May 3, 2012
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophyLuca Bello, Paola Melacini, Raffaele Pezzani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activityChiara Soncini, Patrizia Carpinelli, Laura Gianellini, et al.
Molecular Genetics and Genomics : MGG|March 3, 2016
SNP discovery in common bean by restriction-associated DNA (RAD) sequencing for genetic diversity and population structure analysisPaula Arielle M R Valdisser, Georgios J Pappas, Ivandilson P P de Menezes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 23, 2013
Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophySara Vianello, Hua Yu, Vincent Voisin, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenarioNicolò Danesin, Greta Scapinello, Dorella Del Prete, et al.
Hematological Oncology|November 20, 2012
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapySilvia Mappa, Emerenziana Marturano, Giada Licata, et al.
Giornale Italiano Di Cardiologia (2006)|November 7, 2017
[Cardiogenic shock: from early diagnosis to multiparameter monitoring]Marco Marini, Ilaria Battistoni, Alberto Lavorgna, et al.
Pageof 147